Phibro Animal Health Corporation reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was USD 249.94 million compared to USD 244.65 million a year ago. Net income was USD 1.27 million compared to USD 7.21 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to USD 0.18 a year ago. Diluted earnings per share from continuing operations was USD 0.03 compared to USD 0.18 a year ago.
For the six months, sales was USD 481.29 million compared to USD 477.17 million a year ago. Net loss was USD 6.74 million compared to net income of USD 11.07 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to basic earnings per share from continuing operations of USD 0.27 a year ago. Diluted loss per share from continuing operations was USD 0.17 compared to diluted earnings per share from continuing operations of USD 0.27 a year ago.